Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05536141 |
|---|---|
| Brief Title: | A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors (ARC-20) |
| First Submitted : | September 7, 2022 |
| First Submitted that Met QC Criteria : | September 7, 2022 |
| First Posted : | September 10, 2022 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |